4 weeks Leerink Partnrs Cuts Earnings Estimates for AstraZenecaMarketBeat
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Leerink Partnrs dropped their Q4 2024 earnings per share (EPS) estimates for AstraZeneca in a research report issued to clients and investors on Monday, October 28th. Leerink Partn…
Earnings · Nasdaq 100 · Science
X